These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34218099)

  • 21. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination.
    Parikh SR; Campbell H; Bettinger JA; Harrison LH; Marshall HS; Martinon-Torres F; Safadi MA; Shao Z; Zhu B; von Gottberg A; Borrow R; Ramsay ME; Ladhani SN
    J Infect; 2020 Oct; 81(4):483-498. PubMed ID: 32504737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations].
    Křížová P; Vacková Z; Musílek M; Kozáková J
    Epidemiol Mikrobiol Imunol; 2013 Dec; 62(4):138-47. PubMed ID: 24467175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Need for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands.
    Bousema JC; Ruitenberg J
    Int J Health Policy Manag; 2015 Sep; 4(11):757-61. PubMed ID: 26673336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany.
    Scholz S; Koerber F; Meszaros K; Fassbender RM; Ultsch B; Welte RR; Greiner W
    Vaccine; 2019 Mar; 37(12):1692-1701. PubMed ID: 30661834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reorganization and public health management by the Department of Prevention during the COVID-19 emergency. An experience of integration between prevention and primary care in the proactive management of possible cases].
    Mantovani W; Franchini S; Mazzurana M; Zuccali MG; Pizzo F; Zanin A; Ferro A;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):104-112. PubMed ID: 33412800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies.
    Booy R; Gentile A; Nissen M; Whelan J; Abitbol V
    Hum Vaccin Immunother; 2019; 15(2):470-480. PubMed ID: 30296197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated risk for invasive meningococcal disease among persons with HIV.
    Miller L; Arakaki L; Ramautar A; Bodach S; Braunstein SL; Kennedy J; Steiner-Sichel L; Ngai S; Shepard C; Weiss D
    Ann Intern Med; 2014 Jan; 160(1):30-7. PubMed ID: 24166695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suspected cluster of
    Lawler J; Lucidarme J; Parikh S; Smith L; Campbell H; Borrow R; Gray S; Foster K; Ladhani S
    Euro Surveill; 2019 Jun; 24(23):. PubMed ID: 31186079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada.
    De Wals P; Deceuninck G; Lefebvre B; Tsang R; Law D; De Serres G; Gilca V; Gilca R; Boulianne N
    Clin Infect Dis; 2017 May; 64(9):1263-1267. PubMed ID: 28207068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Australian Meningococcal Surveillance Programme annual report, 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2016 Dec; 40(4):E503-E511. PubMed ID: 28043225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence-Based Risk Mitigation and Stratification During COVID-19 for Return to Interventional Pain Practice: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Shah S; Diwan S; Soin A; Rajput K; Mahajan A; Manchikanti L; Kaye AD; Hirsch JA; Gharibo C
    Pain Physician; 2020 Aug; 23(4S):S161-S182. PubMed ID: 32942784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease.
    Marten O; Koerber F; Bloom D; Bullinger M; Buysse C; Christensen H; De Wals P; Dohna-Schwake C; Henneke P; Kirchner M; Knuf M; Lawrenz B; Monteiro AL; Sevilla JP; Van de Velde N; Welte R; Wright C; Greiner W
    Health Qual Life Outcomes; 2019 May; 17(1):87. PubMed ID: 31118091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive meningococcal disease: Timing and cause of death in England, 2008-2015.
    Beebeejaun K; Parikh SR; Campbell H; Gray S; Borrow R; Ramsay ME; Ladhani SN
    J Infect; 2020 Mar; 80(3):286-290. PubMed ID: 31904388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strong Public Health Recommendations from Weak Evidence? Lessons Learned in Developing Guidance on the Public Health Management of Meningococcal Disease.
    Hanquet G; Stefanoff P; Hellenbrand W; Heuberger S; Lopalco P; Stuart JM
    Biomed Res Int; 2015; 2015():569235. PubMed ID: 26693485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolving global and national criteria for identifying a suspected case of COVID-19.
    Atsawarungruangkit A; Yuan J; Kodama T; Cheng MT; Mansouri M; Han B; Kongkamnerd J; Riegg F; Menon A; Moss SF
    J Int Med Res; 2020 Aug; 48(8):300060520938943. PubMed ID: 32865095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fighting Neisseria meningitidis: past and current vaccination strategies.
    Piccini G; Torelli A; Gianchecchi E; Piccirella S; Montomoli E
    Expert Rev Vaccines; 2016 Nov; 15(11):1393-1407. PubMed ID: 27158988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011.
    Memish Z; Al Hakeem R; Al Neel O; Danis K; Jasir A; Eibach D
    Euro Surveill; 2013 Sep; 18(37):. PubMed ID: 24079399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prolonged outbreak of invasive meningococcal disease in an extended Irish Traveller family across three Health Service Executive (HSE) areas in Ireland, 2010 to 2013.
    O'Connor L; Ward M; Bennett D; Mulhall R; O'Lorcain P; Cunney R; McDermott R; Neville E; Heslin J; FitzGerald R; Meyler K; Conlon M; Clarke A; Corcoran B; Fitzpatrick G; O'Connor B; Flanagan P; O'Flanagan D; Cotter S
    Euro Surveill; 2015 May; 20(21):. PubMed ID: 26062560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical diagnoses and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: Linkage analysis of multiple national databases.
    Edge C; Waight P; Ribeiro S; Borrow R; Ramsay M; Ladhani S
    J Infect; 2016 Nov; 73(5):427-436. PubMed ID: 27475788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological burden of meningococcal disease in Latin America: A systematic literature review.
    Vespa Presa J; Abalos MG; Sini de Almeida R; Cane A
    Int J Infect Dis; 2019 Aug; 85():37-48. PubMed ID: 31085314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.